COMP regulates the TGF-β signaling pathway in skin, pulmonary fibrosis and in atrial fibrosis and is a major pathogenetic factor acting in combination with Ang 2 in the development of atrial fibrillation. Here, COMP is linked to pulmonary fibrosis.